Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London on 23 April, 2026 for the 22nd Annual Anglonordic Life Science Conference.
The conference Programme features on-point panel discussions around European investment and technologies, with 36 funding pitches presented by cutting-edge biomedical and healthcare startups, and 1:1 partnering throughout the day. More than 86 high quality investor firms attended the 2025 conference and they expect a similar number in April.
With the support of M Ventures as lead and founding sponsor, and rich, engaging content devised and coordinated by Optimum Strategic Communications, Anglonordic a top networking and partnering event in the life sciences calendar, and the unique R&D-to-investor conference in the UK.
SwedenBIO members receive a discount. Contact us on info@swedenbio.se if you don’t know where to find our discounts.
More info and Register here
